Option chain shows key data for tZero Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for tZero Group.

tZero Group (OTC:TZROP) Stock, Option Chain

tZero Group Inc is a financial technology company providing transformative market-based solutions for companies, entrepreneurs, and retail & institutional investors. They offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and trade on a regulated alternative trading system.

Fintech news covering the emerging Financial Technology services sector

Fintech

Penny Stocks

HOOD

PYPL

TZERO GRP PFD EQ TKN A by Tzero Group Inc.

TZROP

WONDF

Top News In Fintech And Beyond For June 16, 2022

$BTC

OPFI

TSLA

TWTR

Top News In Fintech And Beyond For April 18, 2022

AAPL

HSBC



Good day! Here are the top things to focus on, today.

Top News In Fintech And Beyond For February 9, 2022

tZero Group Inc

Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) has outperformed the market over the past 5 years by 2.55% on an annualized basis producing an average annual return of 15.52%. Currently, Nucor has a market capitalization of $28.02 billion. 
Buying $100 In NUE: If an investor had bought $100 of NUE stock 5 years ago, it would be worth $205.35 today based on a price of $116.85 for NUE at the time of writing.
<h3>Nucor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734731107_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Nucor Stock In The Last 5 Years

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.13) by 53.85 percent. This is a 60 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.91 million which beat the analyst consensus estimate of $1.72 million by 11.16 percent. This is a 27.49 percent decrease over sales of $2.64 million the same period last year.

Earnings

XELB

Xcel Brands Q3 Adj $(0.06) Beats $(0.13) Estimate, Sales $1.91M Beat $1.72M Estimate

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) announced its Q3 earnings on Friday, December 20, 2024 at 04:30 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Xcel Brands beat estimated earnings by 54.0%, reporting an EPS of $-0.06 versus an estimate of $-0.13.
Revenue was down $725 thousand from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.07, leading to a 2.0% drop share price change the next day.
Here's a look at Xcel Brands's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.08</td>
<td>-0.18</td>
<td>-0.25</td>
<td>-0.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.01</td>
<td>-0.09</td>
<td>-0.24</td>
<td>-0.15</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.62M</td>
<td>2.20M</td>
<td>2.46M</td>
<td>2.80M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.95M</td>
<td>2.18M</td>
<td>2.29M</td>
<td>2.64M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Xcel Brands <a href="https://www.benzinga.com/quote/XELB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Xcel Brands Earnings Report: Q3 Overview

LXRX

Lexicon Receives Complete Response Letter for Zynquista; Says This Expected Communication From The FDA Aligns With Previously Disclosed Strategic Decision To Discontinue Launch Preparations For Zynquista And Focus Solely On Its Clinical Development Pipeline

Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) reported quarterly losses of $(0.12) per share. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The company reported $4.47 million in sales this quarter. This is a 131.04 percent increase over sales of $1.94 million the same period last year.

ILAG

Intelligent Living H1 EPS $(0.12) Up From $(0.16) YoY, Sales $4.47M Up From $1.94M YoY

Common Stock Will Begin Trading on a Split-Adjusted Basis on January 2, 2025
AtlasClear Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NYSE">ATCH</a>) ("AtlasClear Holdings" or the "Company") today announces that it intends to effect a 1-for-60 reverse stock split of its issued and outstanding shares of common stock (the "Reverse Stock Split"). The Reverse Stock Split will become effective on December 31, 2024 (the "Effective Time") upon filing with the Delaware Secretary of State of an amendment to the Company's amended and restated certificate of incorporation (the "Charter"), and the Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on January 2, 2025. The Company's common stock will continue to trade on NYSE American LLC under the symbol "ATCH." The new CUSIP number for the common stock following the Reverse Stock Split will be 128745 205.

Stock Split

ATCH

AtlasClear Holdings Announces 1-For-60 Reverse Stock Split, Common Stock Is Expected To Begin Trading On A Split-Adjusted Basis When The Market Opens On January 2, 2025

The Tesla Model Y electric vehicle from Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) might not win title of Europe's bestselling vehicle for a second straight year, ending a short reign <a href="https://www.benzinga.com/electric-vehicles">for electric vehicles.</a>
What Happened: The Model Y broke records for <a href="https://www.benzinga.com/news/earnings/24/01/36768363/tesla-q4-earnings-highlights-revenue-miss-eps-miss-model-y-a-global-bestseller-next-gen-vehicle-upd">electric vehicles in 2023</a> and became the first EV to be the bestselling car globally for a full year. In Europe, it was the bestseller for 2023.
While the Model Y was Europe's <a href="https://www.benzinga.com/news/23/11/35969553/tesla-model-y-is-likely-bestselling-vehicle-in-europe-for-2023-the-record-breaking-numbers-why-its-i">top seller in 2023,</a> a repeat now appears unlikely.
According to <a href="https://www.autonews.com/retail/sales/ane-europe-top50-november-2024/#:~:text=The%20Tesla%20Model%20Y%20will,as%20Europe's%20top%2Dselling%20car.">data </a>from Automotive News Europe, the Model Y now ranks behind the Dacia Sandero, an internal combustion engine hatchback from French company Renault.
The data, shared by <a href="https://electrek.co/2024/12/19/tesla-model-y-likely-to-lose-its-crown-as-top-selling-car-in-europe-to-dacia-sandero/">Electrek</a>, shows that the Model Y ranks sixth through the month of November. 
The Sandero led the way in November with 21,506 vehicles sold, with the Volkswagen Tiguan second at 18,618.
Year-to-date, the Model Y has 181,781 units sold in Europe, which ranks around 65,000 units behind the Dacia Sandero.
Tesla is offering several incentives through the end of year that could push the vehicle higher up the list, including a year of free charging at Tesla Supercharger locations to anyone who buys a Model Y before the end of the calendar year.
The BYD Song from BYD Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) is mentioned as a top performer for the year with sales up 42% year-over-year.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: With a price point of $13,051, the Dacia Sandero is more appealing to many consumers in Europe looking for a less expensive new car and not willing to spend a higher amount to get an electric vehicle.
Tesla taking the top spot in Europe in 2023 was a great storyline for electric vehicles, but could be hard to replicate without cheaper EV models hitting the country. The Model Y refresh named Juniper and likely coming in 2025, could see Model Y figures get a boost worldwide in 2025.
TSLA Price Action: Tesla stock was down 3% to $421.06 on Friday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is up 70% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/24/10/41166723/how-many-evs-has-tesla-delivered-produced-each-quarter-a-look-at-the-results-since-2019">How Many EVs Has Tesla Delivered, Produced Each Quarter? A Look At The Results Since 2019</a></li>
</ul>
Photo: Dacia Sandero courtesy of Wikimedia Commons

BYDDY

Tesla Model Y Could Lose Bestselling Title In Europe To This Non-EV Car

Legal

QCOM

U.S. Judge Asks Arm And Qualcomm To Mediate After Mistrial, Says Neither Side Has Clear Victory If Case Is Tried Again

FDA Approves Eli Lilly's Zepbound For Moderate-to-Severe Obstructive Sleep Apnea In Adults With Obesity

Offerings

Wendy's Co Files For Mixed Shelf Offering; Size Not Disclosed

Management

ALVR

Allovir Says Diana Brainard Steps Down As CEO; Appointed Vikas Sinha As Company's CEO And Principal Executive Officer

On December 20, 2024, the U.S. Food and Drug Administration approved ALYFTREK&#x2122; (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis in people 6 years and older who have at least one F508del mutation or another mutation in the cystic fibrosis transmembrane conductance regulator gene that is responsive to ALYFTREK.
 &nbsp;
We have established a wholesale acquisition cost for ALYFTREK in the United States of $370,269 on an annual basis ($28,404 per 28-day pack).

VRTX

Vertex Pharmaceuticals Establishes Wholesale Acquisition Cost For Alyftrek In U.S. Of $370,269 On Annual Basis ($28,404 Per 28-day Pack)

Psyence Biomedical Files Prospectus Relates To Potential Offer, Sale, From Time To Time 10.9M Common Shares By Selling Securityholders

Camden National Corporation ("Camden National") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAC#NASDAQ">CAC</a>), the bank holding company for Camden National Bank, announced today that it had received all necessary regulatory approvals to complete its previously announced proposed merger with Northway Financial, Inc. ("Northway") (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NWYF#OTCQB">NWYF</a>), the parent company of Northway Bank. The transaction is expected to close on or about January 2, 2025, pending satisfaction of customary closing conditions.

NWYF

Camden National Receives Regulatory Approvals For Merger Of Northway Financial; Transaction Is Expected To Close On Or About January 2, 2025

FS KKR Capital Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSK#NYSE">FSK</a>) announced that it has priced an underwritten public offering of an additional $100 million in aggregate principal amount of its 6.125% notes due 2030 (the "Notes") pursuant to a reopening of such Notes. The Notes will mature on January 15, 2030 and may be redeemed in whole or in part at&nbsp;FSK's option at any time at par plus a "make-whole" premium, provided that the Notes may be redeemed at par one month prior to their maturity. The offering is expected to close on December 27, 2024, subject to customary closing conditions.

FSK Prices Public Offering Of $100M 6.125% Unsecured Notes Due 2030

Alamo Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALG#NYSE">ALG</a>) announced today that Jeff Leonard, the Company's President and CEO, has informed the Board of Directors of his intention to retire preferably by mid-year 2025 and upon the appointment of his successor.&nbsp;As part of its succession planning efforts, the Company's Board of Directors has been preparing for such a transition and anticipates naming a new President and CEO as Mr. Leonard's replacement within the next several months.&nbsp;

Alamo Group Announces President And CEO Jeff Leonard To Retire Sometime In The Mid-Year Of 2025

WIIM

HOVR

Horizon Aircraft shares are trading higher after the company received an $8.4 million investment.

~ Deepens Investor's Dedication to Horizon Aircraft Supporting Continued Operations and Development ~
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- New Horizon Aircraft Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>), doing business as Horizon Aircraft ("Horizon Aircraft" or the "Company"), a leading hybrid electric Vertical TakeOff and Landing ("eVTOL") aircraft developer, announced today it has received an investment from a strategic investor (the "Investor") and aerospace supporter, for aggregate proceeds of $8.4 million (the "Investment"). The strategic financing will fortify Horizon Aircraft's balance sheet, provide stability in the operations, governance and regulatory priorities, and fund further development and flight testing of its hybrid eVTOL, the Cavorite X7.

Contracts

Horizon Aircraft Has Received An Investment Of $8.4M From A Strategic Investor And Aerospace Supporter

Guidance

Boston Beer Updates 2024 Guidance To Reflect The Impact Of A Negotiated Cash Payment Under An Amendment And Restatement Of An Existing Production Agreement With A Third-Party Supplier, Rauch North America Inc; Company Expects To Record Pre-Tax Contract Settlement Expense Of $26M Or $1.70 After Tax Per Diluted Share Impact In Q4 2024

Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) has outperformed the market over the past 20 years by 3.76% on an annualized basis producing an average annual return of 12.0%. Currently, Norfolk Southern has a market capitalization of $52.97 billion. 
Buying $1000 In NSC: If an investor had bought $1000 of NSC stock 20 years ago, it would be worth $9,824.48 today based on a price of $234.15 for NSC at the time of writing.
<h3>Norfolk Southern's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734729316_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

tZero Group

tZero Group (TZROP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga